ArticleCase reports in oncology

Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study.

Nina Anžič et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.